JPX close: Torii Pharmaceutical (4551.T) at JPY 6,350 on 29 Jan 2026 : watch for an oversold bounce
4551.T stock closed on the JPX at 6,350.00 JPY on 29 Jan 2026, showing an early oversold bounce setup after a pullback toward the year low. Volume was 48,100 shares, slightly below the 49,218 average. The short-term technical picture points to a low-risk mean-reversion trade while fundamentals keep a mixed longer-term view.
Price action: 4551.T stock technical setup
Torii Pharmaceutical (4551.T) opened at 6,340.00 JPY and closed at 6,350.00 JPY on JPX, with a day range of 6,330.00–6,350.00 JPY. The small intraday range and volume near average suggest consolidation after a sell-off. The Keltner midline is 6,350.00 JPY, framing a tight bounce zone.
Valuation and earnings: 4551.T stock fundamentals
Torii reports EPS 192.43 JPY and a trailing PE of 33.00, with price-to-book at 1.46 and price-to-sales at 2.81. The company shows a strong current ratio of 5.18, and cash per share of 1,203.19 JPY, supporting balance-sheet resilience. These metrics limit downside in a bounce trade but argue for cautious sizing.
Meyka grade & forecast: 4551.T stock model
Meyka AI rates 4551.T with a score of 68.86 out of 100 — Grade B (HOLD). This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst consensus. Meyka AI’s forecast model projects 1-year: 5,526.11 JPY, 3-year: 6,581.12 JPY, 5-year: 7,634.08 JPY. Versus the current 6,350.00 JPY, that implies -12.97% at 1 year and +3.64% at 3 years. Forecasts are model-based projections and not guarantees.
Risks & catalysts: 4551.T stock outlook
Near-term catalysts include domestic product uptake for REMITCH and CORECTIM trial updates. Key risks are pricing pressure in generics and slow receivables collection, given days sales outstanding of 159.93. A missed clinical or regulatory update could push the stock back toward the year low of 3,540.00 JPY.
Trading plan: 4551.T stock oversold bounce
For an oversold bounce strategy, consider a tight entry near 6,320.00–6,350.00 JPY, stop-loss at 6,100.00 JPY, and a first target at 6,700.00 JPY. Position size should respect the company’s mixed growth and a PE of 33.00. Use layered exits on rising volume or after reaching the Keltner upper channel at 6,390.00 JPY.
Sector context: 4551.T stock in Healthcare
Healthcare on JPX is up 0.72% YTD but down 0.71% on the day. Torii sits in Drug Manufacturers – Specialty & Generic, where average PE is 23.38. Torii’s PE of 33.00 is premium to peers, reflecting specialty product exposure and steady net margins near 8.52%.
Final Thoughts
Short-term the technicals favour an oversold bounce in 4551.T stock after the JPX close at 6,350.00 JPY on 29 Jan 2026. Use tight risk controls because fundamentals show mixed signals: strong cash per share (1,203.19 JPY) and a high current ratio (5.18), but a trailing PE of 33.00. Meyka AI’s forecast model projects 1-year: 5,526.11 JPY (implied -12.97%) and 3-year: 6,581.12 JPY (implied +3.64%). For traders the recommended near-term target is 6,700.00 JPY with a stop-loss around 6,100.00 JPY. For investors, the Meyka grade B (HOLD) suggests monitoring earnings and regulatory catalysts before increasing exposure. This article uses data from Torii’s site and model-backed analysis by our Meyka AI-powered market analysis platform — act on risk-managed signals
FAQs
Is 4551.T stock a buy after the oversold bounce?
4551.T stock shows a short-term bounce opportunity. For traders, a tight entry and stop work. For longer-term investors, mixed fundamentals and a PE of 33.00 argue for Hold until clearer earnings or regulatory catalysts emerge.
What price target does Meyka AI show for 4551.T stock?
Meyka AI’s forecast model projects 1-year: 5,526.11 JPY and 3-year: 6,581.12 JPY. That implies about -12.97% at 1 year and +3.64% at 3 years versus the current 6,350.00 JPY.
What are the main risks for 4551.T stock?
Main risks for 4551.T stock include regulatory setbacks, pricing pressure in generics, and slow collections given days sales outstanding near 159.93. A negative clinical update could quickly erase short-term gains.
How should I size a trade on 4551.T stock for the oversold bounce?
Size trades small and use a stop-loss around 6,100.00 JPY with a first target near 6,700.00 JPY. Given mixed fundamentals, limit position to a small percentage of the portfolio and scale out on volume-confirmed gains.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
